http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103936756-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-625 |
| filingDate | 2008-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103936756-B |
| titleOfInvention | Compound with blood coagulation resisting function |
| abstract | The invention discloses general structure shown below (1) compound or its salt or its stereoisomer and preparation method, and at least include at least one formula (1) compound or its salt or its stereoisomer as the Pharmaceutical composition of active component. Wherein, R1, R2 and R3 definition is as used in the description.The compound of the present invention has the function of suppressing platelet aggregation, for preventing and treating thrombus or embolism class diseases. |
| priorityDate | 2008-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 90.